The study conducted by Huang and coworkers showed that treatment with 10 and 30 μM of luteolin for 24 h blocked invasion and cell cycle progression of breast cancer cell lines inhibiting the NF-κB pathway and, as a consequence, reducing c-Myc proto-oncogene and hTERT (human telomerase reverse transcriptase) expression levels [71]. Here, NFKB1 is linked to breast carcinoma.